Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Pimonwan Srisook"'
Autor:
Sudjit Luanpitpong, Kantpitchar Tangkiettrakul, Xing Kang, Pimonwan Srisook, Jirarat Poohadsuan, Parinya Samart, Phatchanat Klaihmon, Montira Janan, Chanchao Lorthongpanich, Chuti Laowtammathron, Surapol Issaragrisil
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 12 (2024)
Hematopoiesis continues throughout life to produce all types of blood cells from hematopoietic stem cells (HSCs). Metabolic state is a known regulator of HSC self-renewal and differentiation, but whether and how metabolic sensor O-GlcNAcylation, whic
Externí odkaz:
https://doaj.org/article/d3a38db9865e4659b6c58c118429dc6f
Autor:
Chuti Laowtammathron, Chanchao Lorthongpanich, Nittaya Jiamvoraphong, Pimonwan Srisook, Phatchanat Klaihmon, Pakpoom Kheolamai, Sudjit Luanpitpong, Surapol Issaragrisil
Publikováno v:
Stem Cell Research & Therapy, Vol 14, Iss 1, Pp 1-15 (2023)
Abstract Background In vitro production of hematopoietic stem/progenitor cells (HSPCs) from human-induced pluripotent stem cells (hiPSCs) provides opportunities for fundamental research, disease modeling, and large-scale production of HLA-matched HSP
Externí odkaz:
https://doaj.org/article/12d1c1de258740d8b67336ffc35f0066
Autor:
Pimonwan Srisook, Chuti Laowtammathron, Chanchao Lorthongpanich, Phatchanat Klaihmon, Papussorn Terbto, Supaporn Waeteekul, Yaowalak U-pratya, Surapol Issaragrisil
Publikováno v:
Stem Cell Research, Vol 67, Iss , Pp 103035- (2023)
Runt-Related Transcription Factor 1c (RUNX1c) plays an important role in regulating the development of hematopoietic stem cells (HSC). Using CRISPR/Cas9 gene editing technology, we established a RUNX1c-eGFP reporter cell line from the MUSIi012-A cell
Externí odkaz:
https://doaj.org/article/d644fb3cbefc4e92a17aa4b8ecfa6296
CRISPR/Cas9 mediated approach to generate YAP-depleted human embryonic stem cell line (MUSIe002-A-1)
Autor:
Sujittra Khampang, Nittaya Jiamvoraphong, Chuti Laowtammathron, Chanchao Lorthongpanich, Phatchanat Klaihmon, Pimonwan Srisook, Xing Kang, Sudjit Luanpitpong, Yaowalak U-pratya, Surapol Issaragrisil
Publikováno v:
Stem Cell Research, Vol 66, Iss , Pp 102990- (2023)
Yes-associated protein (YAP), an important effector protein of the Hippo signaling pathway, acts as a molecular switch in controlling cell proliferation and apoptosis. In this study, a YAP-targeted isogenic sub-clone of the MUSIe002-A was generated,
Externí odkaz:
https://doaj.org/article/425db2b7d3ab43e08b084b07c92f5e9a
Autor:
Sujittra Khampang, Chuti Laowtammathron, Chanchao Lorthongpanich, Phatchanat Klaihmon, Pimjai Chingsuwanrote, Roungsin Choavaratana, Suphadtra Phornwilardsiri, Ketsara Sitthirit, Pimonwan Srisook, Yaowalak U-pratya, Surapol Issaragrisil
Publikováno v:
Stem Cell Research, Vol 59, Iss , Pp 102660- (2022)
The MUSIe002-A cell line was established from in vitro fertilization of human sperm and oocytes donated for research with informed consent. This cell line exhibited normal human embryonic stem cell (hESC) characteristics, including typical cell morph
Externí odkaz:
https://doaj.org/article/03ee19a47cf145e3b71590af0928b086
Autor:
Chanchao Lorthongpanich, Chuti Laowtammathron, Nittaya Jiamvoraphong, Pimonwan Srisook, Pimjai Chingsuwanrote, Phatchanat Klaihmon, Supaporn Waeteekul, Yaowalak U-pratya, Surapol Issaragrisil
Publikováno v:
Stem Cell Research, Vol 48, Iss , Pp 101950- (2020)
In mammals, there are a number of kinases, including serine/threonine-protein kinase LATS1, that act as a core kinase of the Hippo pathway and that negatively regulate the Hippo effector protein YAP and its paralog TAZ. Using CRISPR/Cas9 technology,
Externí odkaz:
https://doaj.org/article/b3a963287f2944c0a8d8038ff35ec224
Autor:
Chanchao Lorthongpanich, Chuti Laowtammathron, Nittaya Jiamvoraphong, Pimonwan Srisook, Pimjai Chingsuwanrote, Phatchanat Klaihmon, Nattaya Damkham, Papussorn Terbto, Supaporn Waeteekul, Yaowalak U-pratya, Surapol Issaragrisil
Publikováno v:
Stem Cell Research, Vol 43, Iss , Pp - (2020)
Yes-associated protein (YAP) is an important transcriptional coactivator in the Hippo signaling pathway. Using CRISPR/Cas9 technology, we established a stable YAP-knockdown (YAP-KD) induced pluripotent stem cell (iPSC) from the MUSIi012-A cell line.
Externí odkaz:
https://doaj.org/article/ccf4a99c910e42cdbe6b50ea608c9824
Autor:
Chuti Laowtammathron, Pimjai Chingsuwanrote, Roungsin Choavaratana, Suphadtra Phornwilardsiri, Ketsara Sitthirit, Chidchanok Kaewjunun, Orawan Makemaharn, Papussorn Terbto, Supaporn Waeteekul, Chanchao Lorthongpanich, Yaowalak U-pratya, Pimonwan Srisook, Pakpoom Kheolamai, Surapol Issaragrisil
Publikováno v:
Stem Cell Research, Vol 43, Iss , Pp - (2020)
MUSIe001-A cell line was derived from a Southeast Asian (SEA) type deletion α0-thalassemia embryo. The SEA deletion embryo was donated for research with informed consent. This cell line shows normal hESC morphology, expresses all pluripotent markers
Externí odkaz:
https://doaj.org/article/8c20a03101e54969ae3989a05507c559
Autor:
Chuti Laowtammathron, Pimjai Chingsuwanrote, Roungsin Choavaratana, Suphadtra Phornwilardsiri, Ketsara Sitthirit, Chidchanok Kaewjunun, Orawan Makemaharn, Papussorn Terbto, Supaporn Waeteekul, Chanchao Lorthongpanich, Yaowalak U-pratya, Pimonwan Srisook, Pakpoom Kheolamai, Surapol Issaragrisil
Publikováno v:
Stem Cell Research & Therapy, Vol 9, Iss 1, Pp 1-10 (2018)
Abstract Background Due to their extensive self-renewal and multilineage differentiation capacity, human embryonic stem cells (hESCs) have great potential for studying developmental biology, disease modeling, and developing cell replacement therapy.
Externí odkaz:
https://doaj.org/article/8f3ec3a61fd74e439902a04c27f7060e
Autor:
Chuti Laowtammathron, Pimonwan Srisook, Pimjai Chingsuwanrote, Nittaya Jiamvoraphong, Supaporn Waeteekul, Papussorn Terbto, Yaowalak U-Pratya, Chanchao Lorthongpanich, Surapol Issaragrisil
Publikováno v:
Stem Cell Research, Vol 41, Iss , Pp - (2019)
CD34+ cells were isolated from mobilized peripheral blood of a healthy donor and reprogrammed by nucleofection with episomal plasmids carrying l-MYC, LIN28, OCT4, SOX2, KLF4, EBNA-1, and shRNA against p53. The obtained MUSIi012-A cell line maintained
Externí odkaz:
https://doaj.org/article/0454a7e6cb4942329f4687e0f943df22